Dr Lang on Real-World Outcomes With the KEYNOTE-522 Regimen in Early-Stage TNBC | OncLive
onclive.com
Dr Lang on Real-World Outcomes With the KEYNOTE-522 Regimen in Early-Stage TNBC | OncLive
Julie Lang, MD, discusses real-world outcomes of the neoadjuvant KEYNOTE-522 regimen in patients with early-stage triple-negative breast cancer.
Feb 11, 2025
Pembrolizumab Uses
Identifying Uses for Immunotherapy Across Sarcoma Populations and Subtypes | CancerNetwork
Identifying Uses for Immunotherapy Across Sarcoma Populations and Subtypes | CancerNetwork
cancernetwork.com
1 month ago
Keytruda (pembrolizumab) vedlejší účinky, interakce, použití a otisk drogy - Zdraví 2026
Keytruda (pembrolizumab) vedlejší účinky, interakce, použití a otisk drogy - Zdraví 2026
oldmedic.com
Aug 24, 2019
Primary Results from the Phase 3 Leap-002 Study: Lenvatinib plus Pembrolizumab versus Lenvatinib as First-Line Therapy for Advanced Hepatocellular Carcinoma | OncLive
Primary Results from the Phase 3 Leap-002 Study: Lenvatinib plus Pembrolizumab versus Lenvatinib as First-Line Therapy for Advanced Hepatocellular Carcinoma | OncLive
onclive.com
Sep 29, 2022
Top videos
Julie Lang, MD, discusses real-world outcomes of the neoadjuvant KEYNOTE-522 regimen in patients with early-stage triple-negative breast cancer. Watch more here: https://hubs.li/Q036f4kJ0 | OncLive
0:50
Julie Lang, MD, discusses real-world outcomes of the neoadjuvant KEYNOTE-522 regimen in patients with early-stage triple-negative breast cancer. Watch more here: https://hubs.li/Q036f4kJ0 | OncLive
FacebookOncLive
122 viewsFeb 12, 2025
Dr. Rugo on the Results of the KEYNOTE-522 Trial in TNBC | OncLive
Dr. Rugo on the Results of the KEYNOTE-522 Trial in TNBC | OncLive
onclive.com
May 21, 2020
KEYNOTE-522: Immune therapy and chemotherapy in patients with early triple negative breast cancer
8:05
KEYNOTE-522: Immune therapy and chemotherapy in patients with early triple negative breast cancer
YouTubeecancer
264 viewsOct 10, 2019
Pembrolizumab Side Effects
Pembrolizumab (Keytruda): How It Works, Side Effects & What Patients Should Know
14:04
Pembrolizumab (Keytruda): How It Works, Side Effects & What Patients Should Know
YouTubeDEMIRxCARE
54 views4 months ago
💊What is PEMBROLIZUMAB?. Mechanism of Action, Dosage and Side Effects of Pembrolizumab (KEYTRUDA)💊
13:24
💊What is PEMBROLIZUMAB?. Mechanism of Action, Dosage and Side Effects of Pembrolizumab (KEYTRUDA)💊
YouTubeMedicines/Diseases
1.6K viewsJun 4, 2020
Keytruda (pembrolizumab) Benefits & Side effects
1:19
Keytruda (pembrolizumab) Benefits & Side effects
YouTubeariflive
40 views11 months ago
Julie Lang, MD, discusses real-world outcomes of the neoadjuvant KEYNOTE-522 regimen in patients with early-stage triple-negative breast cancer. Watch more here: https://hubs.li/Q036f4kJ0 | OncLive
0:50
Julie Lang, MD, discusses real-world outcomes of the neoadjuva…
122 viewsFeb 12, 2025
FacebookOncLive
Dr. Rugo on the Results of the KEYNOTE-522 Trial in TNBC | OncLive
Dr. Rugo on the Results of the KEYNOTE-522 Trial in TNBC | Onc…
May 21, 2020
onclive.com
KEYNOTE-522: Immune therapy and chemotherapy in patients with early triple negative breast cancer
8:05
KEYNOTE-522: Immune therapy and chemotherapy in patients with earl…
264 viewsOct 10, 2019
YouTubeecancer
🩷 Early-Stage Triple Negative Breast Cancer (TNBC) ✔️ Sa KEYNOTE-522, mas mataas ang pCR sa chemo pembrolizumab (~65%) kumpara sa chemo alone (~51%). ✔️ Mas bumaba ang risk ng recurrence at mas gumanda ang event-free survival. ✔️ Kung chemo lang ang kaya — effective pa rin ito. ✔️ Kung may residual disease, may dagdag na proteksyon ang capecitabine (CREATE-X trial). ✔️ Huwag kalimutan ang breast tissue marker bago chemo para mas accurate at safe ang breast-conserving surgery. 🩺 Hindi pare-pare
2:45
🩷 Early-Stage Triple Negative Breast Cancer (TNBC) ✔️ Sa KEYNOTE-…
2K views3 months ago
FacebookDr. Emmeline De Los Santos- Cancer Surgeon …
Newly diagnosed with Triple Negative Breast Cancer
13:26
Newly diagnosed with Triple Negative Breast Cancer
1.3K views5 months ago
YouTubeLaura G
KEYNOTE-522: pembrolizumabe em pacientes com câncer de mama triplo negativo inicial - Oncologia Brasil
KEYNOTE-522: pembrolizumabe em pacientes com câncer de mama tri…
Dec 9, 2021
oncologiabrasil.com.br
KEYNOTE-522 Demonstrates Potential for Immunotherapy in Triple-Negative Breast Cancer
0:53
KEYNOTE-522 Demonstrates Potential for Immunotherapy in Tri…
538 viewsOct 31, 2019
YouTubeTargeted Oncology
4:54
KEYNOTE-522 updates: Pembrolizumab plus neoadjuvant …
734 viewsJan 7, 2020
YouTubeecancer
Dr. Costa on the Implications of the KEYNOTE-522 Trial in TNBC | Onc…
Feb 15, 2023
onclive.com
1:55
Watch Peter Schmid, MD, PhD, FRCP, of Barts Cancer Insitute dis…
55 viewsDec 4, 2024
FacebookOncLive
4:50
Triple Negative Breast Cancer Update: Immunotherapy in stage …
4.3K viewsSep 17, 2024
YouTubeEleonora Teplinsky, MD
0:52
Immunotherapy - keytruda. Finishing keynote 522 for TNBC. #…
883 viewsApr 9, 2024
TikTokcutiecuban2.0
14:21
Halftime Recap Of Chemotherapy for Triple Negative Breast Cancer
1.2K views3 months ago
YouTubeLaura G
4:20
KEYNOTE-522: 5-year follow-up of pembrolizumab in triple-negative …
4.7K viewsOct 25, 2023
YouTubeVJOncology
14:06
Recap of chemo side effects from infusion #3 of Keynote 522 treatm…
335 views3 months ago
YouTubeLaura G
20:27
Chemo for Triple Negative Breast Cancer is Finished!!
173 views2 weeks ago
YouTubeLaura G
9:47
Immunotherapy in Early Breast Cancer: Hope or Hype?
1.4K viewsJun 29, 2024
YouTubeCancer Treatment Updates
6:31
KEYNOTE-522: Event-Free Survival With Neoadjuvant and Adjuvant P…
Dec 15, 2023
targetedonc.com
KEYNOTE-522: Neoadjuvant and Adjuvant Pembrolizumab in TNB…
Jun 1, 2022
onclive.com
Case Review and KEYNOTE-522 Insights: Discussing Neoadjuvant …
153 views9 months ago
vumedi.com
5:49
Neoadjuvant Treatment for Triple-Negative Breast Cancer
3.8K viewsMar 12, 2020
YouTubeOncLive
1:29
Immunotherapy Keytruda Shows Benefit in Early Triple-Negative Br…
3.2K viewsDec 19, 2019
YouTubeBreastcancer.org
5:55
Positive KEYNOTE-522 Overall Survival Results in TNBC | AJMC
Sep 16, 2024
ajmc.com
SABCS 2022 Post Hoc Analysis of Adjuvant RT in the Phase 3 KEYN…
Dec 21, 2022
vumedi.com
11:45
SABCS Snippets: KEYNOTE-522 Phase 3 Results
660 viewsMay 29, 2024
YouTubeSan Antonio Breast Cancer Symposium
1:37
How to adapt the KEYNOTE-522 without cyclophosphamide
170 views1 month ago
YouTubeClube da Mama
17:14
SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA U…
3K viewsDec 15, 2023
YouTubeOncBrothers: Practice-Changing Cancer Discus…
3:09
KEYNOTE-522: Neoadjuvant and adjuvant pembrolizumab for early …
2.2K viewsSep 22, 2021
YouTubeVJOncology
ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522…
Sep 24, 2024
vumedi.com
See more videos
Static thumbnail place holder